The tumour volume measured by BLI of the CD133 CAR-T and PD-1 s cell group was smaller than that of the CD133-specific CAR-T and Mock T-cell-treated groups on day 21 (P = 0.0079 and P = 0.0159, respectively; Fig. 5D). This evidence concerns the gene PROM1 and neoplasm.